ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Meeting News

A Real Tail in These Curves: A Look at Advances and Future Directions in SCLC

Haleigh Behrman
on: April 22, 2025In: Meeting News, Society News
A Real Tail in These Curves: A Look at Advances and Future Directions in SCLC

During a recent address at SCLC 2025, Dr. Charles Rudin discussed the progress being made in reducing the incidence of small cell lung cancer and in treating it. Read more


COCOON Regimen Demonstrates Improvement in Dermatologic Toxicities

Nathan Pettengill
on: April 22, 2025In: Meeting News, Society News
COCOON Regimen Demonstrates Improvement in Dermatologic Toxicities

Dr. Nicolas Girard recently presented data that shows prophylactic treatment with oral and topical antibiotics and ceramide-based moisturizer significantly reduced adverse skin events. Read more

Savolitinib Plus Osimertinib Offers Hope for Addressing Resistance, Progression

Nathan Pettengill
on: April 22, 2025In: Meeting News, Society News
Savolitinib Plus Osimertinib Offers Hope for Addressing Resistance, Progression

Dr. Myung-Ju Ahn said recent data from SAVANNAH show the combination produced a meaningful and durable response in patients whose cancer progressed after osimertinib. Read more

Final MARIPOSA Analysis Confirms OS Improvement Versus Osimertinib Monotherapy

Haleigh Behrman
on: April 08, 2025In: Meeting News, Society News
Final MARIPOSA Analysis Confirms OS Improvement Versus Osimertinib Monotherapy

Drs. Chih-Hsin Yang and Pérol reviewed the latest findings and key takeaways during a presentation at the European Lung Cancer Congress. Read more

Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award

Nathan Pettengill
on: April 08, 2025In: Meeting News, Names & News, Society News
Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award

During his award lecture at the European Lung Cancer Congress, Dr. Kerr said lung cancer treatment has benefited from the bridging of the historical divide between pathology and medical oncology. Read more

Combination Therapies as Frontline Treatment for EGFR-Mutated NSCLC: Are the Rewards Worth the Risks?

Haleigh Behrman
on: March 25, 2025In: Evolving Standards of Care, Meeting News, Names & News
Combination Therapies as Frontline Treatment for EGFR-Mutated NSCLC: Are the Rewards Worth the Risks?

During a TTLC debate, Drs. Helena Yu and Shirish Gadgeel weighed the pros and limitations of osimertinib monotherapy and combination therapies. Read more

With Data on Her Side, Dr. Anne Tsao Dominates Debate on Merits of Chemo-IO for Mesothelioma

Haleigh Behrman
on: March 25, 2025In: Evolving Standards of Care, Meeting News, Names & News
With Data on Her Side, Dr. Anne Tsao Dominates Debate on Merits of Chemo-IO for Mesothelioma

Lacking evidence to argue against combinations in this patient population, Dr. Penelope Bradbury, turned to humor to make her case. Read more

Will Bispecific Antibodies Replace PD-(L)1 Targeted Agents?

Nathan Pettengill
on: March 11, 2025In: Meeting News, Names & News, Society News
Will Bispecific Antibodies Replace PD-(L)1 Targeted Agents?

Drs. Jonathan W. Riess and Greg Kalemkerian present opposing views regarding the therapeutic potential of novel targeted therapies. Read more

Debate Leaves Audience Unconvinced that KRAS Inhibitors Deserve Promotion to First-Line Treatment

Nathan Pettengill
on: March 11, 2025In: Meeting News, Names & News, Society News
Debate Leaves Audience Unconvinced that KRAS Inhibitors Deserve Promotion to First-Line Treatment

While Dr. Trever Bivona argued that KRAS inhibitors will join other seminal oncogene inhibitors, Dr. Rebecca Heist said the data has yet to demonstrate they outperform the current second-line standard of care. Read more

Where There’s Smoke: The Global Threat of Lung Cancer in Patients with No Smoking History and its Implications in Screening

Haleigh Behrman
on: February 25, 2025In: Meeting News, Risk Assessment and Reduction, Screening/ED
Where There’s Smoke: The Global Threat of Lung Cancer in Patients with No Smoking History and its Implications in Screening

Dr. Lucia Viola says that access to genomic profiling is crucial for gathering information about patients who do not smoke. Read more

‹12345›»

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy